A 43-year-old man is brought to the emergency department 45 minutes after his wife found him on the floor sweating profusely. On arrival, he is lethargic and unable to provide a history. He vomited multiple times on the way to the hospital. His temperature is 37.3°C (99.1°F), pulse is 55/min, respirations are 22/min, and blood pressure is 98/65 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 80%. Examination shows profuse diaphoresis and excessive salivation. He withdraws his extremities sluggishly to pain. The pupils are constricted and reactive. Scattered expiratory wheezing and rhonchi are heard throughout both lung fields. Cardiac examination shows no abnormalities. There are fine fasciculations in the lower extremities bilaterally. Muscle strength is reduced and deep tendon reflexes are 1+ bilaterally. His clothes are soaked with urine and feces. Which of the following is the mechanism of action of the most appropriate initial pharmacotherapy?

Competitive antagonism of mACh receptors

Non-selective α-adrenergic antagonism

A 28-year-old woman, gravida 1, para 0, at 32 weeks' gestation is admitted to the hospital for the management of elevated blood pressures. On admission, her pulse is 81/min, and blood pressure is 165/89 mm Hg. Treatment with an intravenous drug is initiated. Two days after admission, she has a headache and palpitations. Her pulse is 116/min and regular, and blood pressure is 124/80 mm Hg. Physical examination shows pitting edema of both lower extremities that was not present on admission. This patient most likely was given a drug that predominantly acts by which of the following mechanisms?

Direct dilation of the arterioles

Inhibition of β1, β2, and α1 receptors

Inhibition of angiotensin II production

Activation of α2 adrenergic receptors

Inhibition of sodium reabsorption

A researcher is studying receptors that respond to epinephrine in the body and discovers a particular subset that is expressed in presynaptic adrenergic nerve terminals. She discovers that upon activation, these receptors will lead to decreased sympathetic nervous system activity. She then studies the intracellular second messenger changes that occur when this receptor is activated. She records these changes and begins searching for analogous receptor pathways. Which of the following receptors would cause the most similar set of intracellular second messenger changes?

Dopamine receptors in the brain

Muscarinic cholinoreceptors in the gastrointestinal tract

Growth hormone receptors in the musculoskeletal system

Vasopressin receptors in the kidney

Aldosterone receptors in the kidney

A 58-year-old woman presents to her physician complaining of a headache in the occipital region for 1 week. Past medical history is significant for essential hypertension, managed with lifestyle modifications and 2 antihypertensives for the previous 6 months. Her blood pressure is 150/90 mm Hg. Neurological examination is normal. A third antihypertensive drug is added that acts as a selective α2 adrenergic receptor agonist. On follow-up, she reports that she does not have any symptoms and her blood pressure is 124/82 mm Hg. Which of the following mechanisms best explains the therapeutic effect of this new drug in this patient?

Decreased peripheral sympathetic outflow

Vasodilation of peripheral arteries

Vasodilation of peripheral arteries and peripheral veins

Negative inotropic effect on the heart

Vasodilation of peripheral veins

Autonomic drug interactions — USMLE Lesson

ANS Pharmacology - The Players & The Field

Cholinergic Receptors (ACh):
- Nicotinic ($N_N, N_M$): Autonomic ganglia, adrenal medulla, neuromuscular junction.
- Muscarinic ($M_1, M_2, M_3$): Glands, smooth muscle, heart.
Adrenergic Receptors (NE, Epi):
- Alpha ($\.alpha_1, \.alpha_2$): Vascular smooth muscle (vasoconstriction), presynaptic terminals.
- Beta ($\.beta_1, \.beta_2$): Heart (↑ rate/contractility), Lungs (bronchodilation).

Adrenergic Receptor Subtypes, Locations, and Effects

⭐ At low doses, dopamine stimulates D1 receptors (renal vasodilation); at medium doses, B1 receptors (↑ cardiac contractility); at high doses, a1 receptors (vasoconstriction).

📌 G-Protein Coupling: "QISS and QIQ" for ($\.alpha_1, \.alpha_2, \.beta_1, \.beta_2$) and ($M_1, M_2, M_3$).

Adrenergic Interactions - The Reversal Heist

Epinephrine Reversal: A paradoxical fall in Mean Arterial Pressure (MAP) when epinephrine is given after a non-selective α-blocker (e.g., phentolamine, phenoxybenzamine).
Mechanism:
- Normally, epinephrine stimulates α1 (vasoconstriction) and β2 (vasodilation). The α1 effect dominates, causing ↑ MAP.
- After an α-blocker, the α1 vasoconstriction is blocked. Epinephrine's β2-mediated vasodilation becomes unopposed, causing ↓ Total Peripheral Resistance (TPR) and a fall in MAP.
- 📌 Mnemonic: Alpha-blockade before epi makes the pressure dip!

⭐ This reversal is unique to mixed α/β agonists. The pressor effect of a pure α-agonist like phenylephrine is simply abolished, not reversed. Norepinephrine's effect is blunted but not reversed due to its weak β2 activity.

Cholinergic Interactions - The SLUDGE-fest

Cholinergic synapse with and without AChE inhibition

Additive Toxicity (Cholinergic Crisis): Occurs when multiple cholinergic agents are combined.
- Examples: Cholinomimetics (pilocarpine, bethanechol) + AChE inhibitors (neostigmine, physostigmine).
- Leads to a "SLUDGE-fest" of muscarinic overstimulation.
- 📌 SLUDGE: Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis.
Antagonism: Cholinergic effects can be blocked by antimuscarinic agents.
- Atropine: A competitive inhibitor at muscarinic receptors; reverses CNS and peripheral muscarinic effects of organophosphate poisoning.
- Pralidoxime: Regenerates AChE, reversing both muscarinic and nicotinic effects of organophosphates.

⭐ In organophosphate poisoning, atropine treats the muscarinic "SLUDGE" symptoms but does not reverse the nicotinic effect of muscle paralysis. Pralidoxime is required for this.

Systemic Effects - The Cardio Crossover

Baroreceptor Reflex: A key homeostatic loop. Drug effects can be direct (on vessels/heart) or indirect (reflex-mediated).
- An ↑ in BP triggers a reflex ↓ in HR.
- A ↓ in BP triggers a reflex ↑ in HR.
Clinical Interaction Example:
- Phenylephrine (pure α₁-agonist) → potent vasoconstriction → ↑ BP.
- The body compensates via the baroreceptor reflex → ↑ vagal tone → ↓ HR (reflex bradycardia).

⭐ Pre-treatment with atropine (a muscarinic antagonist) blocks the M₂ receptors on the heart, thus preventing the reflex bradycardia caused by agents like phenylephrine.

High‑Yield Points - ⚡ Biggest Takeaways

Beta-blockers can blunt the therapeutic effects of beta-agonists (e.g., albuterol), which is dangerous in asthmatics.

Alpha-blockers (e.g., phentolamine) can cause epinephrine reversal, a paradoxical hypotension from unopposed β2-mediated vasodilation.

MAOIs with tyramine-rich foods (wine, cheese) can precipitate a hypertensive crisis.

TCAs and cocaine block norepinephrine reuptake, potentiating direct-acting sympathomimetics.

Cholinesterase inhibitors reverse non-depolarizing neuromuscular blockade but potentiate succinylcholine.

Atropine reverses the muscarinic effects of cholinesterase inhibitor toxicity.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

UNLOCK FREE ACCESS